Heparin defends against the toxicity of circulating histones in sepsis.

Wang, Feifei; Zhang, Naipu; Li, Biru; Liu, Lanbo; Ding, Lei; Wang, Ying; Zhu, Yimin; Mo, Xi; Cao, Qing

Wang, Feifei; Zhang, Naipu; Li, Biru; Liu, Lanbo; Ding, Lei; Wang, Ying; Zhu, Yimin; Mo, Xi; Cao, Qing.

Affiliation

Wang Y; Department of Clinical Biochemistry, Chinese PLA General Hospital, No.28, Fuxing Road, Beijing, China, 100853.
Cao Q; Department of infectious diseases, Shanghai Children's Medical Center, 1678 Dongfang Rd., Shanghai, 200127, China, caoqing9@yeah.net.

Front Biosci (Landmark Ed) ; 20(8): 1259-70, 2015 06 01.

Article in En | MEDLINE | ID: mdl-25961556

Subject(s)

Heparin/therapeutic use; Histones/blood; Protective Agents/therapeutic use; Sepsis/blood; Animals; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Histones/toxicity; Human Umbilical Vein Endothelial Cells; Humans; Infant; Male; Mice; Mice, Inbred C57BL

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Heparin / Histones / Sepsis / Protective Agents Type of study: Prognostic_studies Limits: Animals / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Front Biosci (Landmark Ed) Year: 2015 Type: Article

Search on Google

XML

PubMed Links